Oncolys BioPharma Hits Day High with 11.23% Surge in Stock Price

Oncolys BioPharma, Inc. has experienced a significant surge in its stock price, gaining 11.23% on March 24, 2026. The stock reached an intraday high of JPY 2,525.00, marking a notable performance compared to the Japan Nikkei 225, which rose by only 1.43% on the same day. Over the past week, Oncolys BioPharma has shown a robust increase of 9.19%, while the Nikkei 225 declined by 2.7%. In the longer term, the company has demonstrated impressive growth, with a remarkable 226.7% increase over the past year, significantly outperforming the Nikkei 225's 38.94% gain. Year-to-date, the stock has risen by 76.81%, further highlighting its strong performance relative to the broader market. Despite these gains, Oncolys BioPharma faces challenges, including a negative return on equity of -115.09% and a concerning operating profit decline over the past five years. The company's market capitalization stands at JPY 56,914 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology industry.